TABLE 2.
Variable | Men (N=18)
|
Women (N=12)
|
||
---|---|---|---|---|
Mean | SD | Mean | SD | |
Age | 38.6 | 10.4 | 36.0 | 9.2 |
Age at onset | 20.1 | 3.8 | 20.4 | 8.2 |
Duration of illness | 18.5 | 9.7 | 15.6 | 6.7 |
Antipsychotic dosage (chlorpromazine equivalents)a | 433 | 319 | 395 | 458 |
Brief Psychiatric Rating Scale score | 31.5 | 11.3 | 31.0 | 8.6 |
Scale for the Assessment of Negative Symptoms | ||||
Total (items 1–22) | 33.8 | 27.8 | 30.3 | 17.7 |
Affect (items 1–8) | 8.6 | 8.2 | 5.5 | 5.6 |
Alogia (items 9–13) | 3.6 | 6.0 | 2.8 | 2.9 |
Avolition (items 14–17) | 5.7 | 5.2 | 5.3 | 4.4 |
Anhedonia (items 18–22) | 8.9 | 6.7 | 8.2 | 6.7 |
Attention (items 23–25) | 2.6 | 4.9 | 2.6 | 2.8 |
Scale for the Assessment of Positive Symptoms | ||||
Total (items 1–34) | 18.4 | 21.8 | 13.1 | 11.6 |
Hallucination items (1–7) | 4.4 | 6.5 | 7.0 | 6.8 |
Delusion items (8–20) | 9.7 | 11.3 | 4.2 | 6.5 |
Bizarre behavior items (21–25) | 1.4 | 2.4 | 0.0 | 0.0 |
Formal thought disorder items (26–34) | 2.9 | 7.4 | 1.9 | 4.0 |
Two male patients and two female patients were unmedicated.